The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ prolapse.
The aim of this study is to validate the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) in Portuguese. Two hundred four women (108 symptomatic, 94 asymptomatic, and two with no data) with mean age of 55.4 years received a Portuguese version of the ICIQ-VS. Clinical data and pelvic organ prolapse quantification index (POP-Q) were obtained. Retest was performed 3 weeks later. Responsiveness was assessed after 20 weeks of postsurgical follow-up. Overall, most patients presented POP-Q > 2. ICIQ-VS demonstrated good psychometric properties (validity, reliability and responsiveness). The test-retest reliability was moderate to excellent for all questions. The construct validation distinguished differences in ICIQ-VS scores between symptomatic (ICIQ-VS5a > 0) and asymptomatic (ICIQ-VS5a = 0) women. ICIQ-VS was highly responsive to surgical treatment and discriminated between levels of change in the vaginal symptoms score, sexual matters score, quality-of-life score, and POP-Q. The Portuguese version of ICIQ-VS was successfully validated.
Tamanini
José Tadeu Nunes
JT
State Center for Voiding Dysfunction, Rua Riachuelo, 899, 17201-340, Jaú, SP, Brazil. tadeutamanini@jau.flash.tv.br
Almeida
Fernando G
FG
Girotti
Marcia Eli
ME
Riccetto
Cássio L Z
CL
Palma
Paulo C R
PC
Rios
Luis Augusto S
LA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001938:Brazil / Q000453:epidemiology; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007391:International Cooperation; D008875:Middle Aged; D011174:Portugal; D011788:Quality of Life; D012017:Referral and Consultation; D015203:Reproducibility of Results; D012189:Retrospective Studies; D011795:Surveys and Questionnaires / Q000592:standards*; D014549:Urinary Incontinence / Q000175:diagnosis* / Q000453:epidemiology; D014596:Uterine Prolapse / Q000175:diagnosis* / Q000453:epidemiology